Keunchil Park Selected Research

Thymic epithelial tumor

1/2020	Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment.
1/2019	Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keunchil Park Research Topics

Disease

254	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2002
152	Neoplasms (Cancer) 04/2024 - 09/2002
44	Disease Progression 01/2024 - 01/2006
33	Adenocarcinoma 05/2023 - 03/2006
27	Lung Neoplasms (Lung Cancer) 11/2023 - 11/2002
26	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2003
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 12/2003
19	Adenocarcinoma of Lung 01/2023 - 11/2002
13	Exanthema (Rash) 01/2022 - 07/2004
12	Carcinoma (Carcinomatosis) 01/2020 - 11/2002
11	Neutropenia 05/2023 - 01/2004
11	Diarrhea 01/2023 - 01/2004
9	Esophageal Squamous Cell Carcinoma 01/2022 - 10/2005
8	Nausea 05/2023 - 01/2007
8	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2006
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2007 - 09/2002
7	Thrombocytopenia (Thrombopenia) 05/2023 - 11/2004
7	Vomiting 01/2023 - 01/2007
7	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2018 - 02/2010
7	Fatigue 01/2018 - 05/2007
6	Febrile Neutropenia 05/2023 - 07/2008
6	Hypertension (High Blood Pressure) 01/2020 - 04/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 06/2008
5	Pneumonia (Pneumonitis) 10/2023 - 01/2018
5	Squamous Cell Carcinoma of Head and Neck 10/2023 - 08/2011
5	Anemia 10/2023 - 01/2004
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 08/2002
5	Stomach Neoplasms (Stomach Cancer) 06/2021 - 10/2004
5	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2016 - 10/2003
5	Acne Vulgaris 01/2016 - 05/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2004
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2003
4	Fever (Fevers) 01/2022 - 08/2013
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 05/2015
4	Nasopharyngeal Carcinoma 02/2016 - 06/2015
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2010 - 07/2006
4	Breast Neoplasms (Breast Cancer) 11/2009 - 10/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2007 - 01/2003
3	Large Cell Carcinoma 05/2023 - 07/2008
3	Pleural Effusion (Pleural Effusions) 01/2022 - 10/2009

Drug/Important Bio-Agent (IBA)

81	ErbB Receptors (EGF Receptor)IBA 01/2024 - 04/2007
68	Tyrosine Kinase InhibitorsIBA 01/2024 - 07/2009
41	Cisplatin (Platino)FDA LinkGeneric 05/2023 - 01/2002
39	PlatinumIBA 02/2024 - 10/2003
32	Gefitinib (Iressa)FDA Link 01/2021 - 07/2004
27	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 04/2007
25	Pemetrexed (MTA)FDA Link 05/2023 - 07/2008
24	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2002
21	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
21	AfatinibIBA 07/2022 - 05/2012
19	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2009
16	osimertinibIBA 01/2024 - 01/2016
16	Gemcitabine FDA Link 05/2023 - 01/2004
14	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 02/2003
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2003
11	Anaplastic Lymphoma KinaseIBA 01/2023 - 05/2012
9	pembrolizumabIBA 04/2024 - 01/2016
9	durvalumabIBA 02/2024 - 04/2017
9	Phosphotransferases (Kinase)IBA 10/2023 - 04/2007
9	Monoclonal AntibodiesIBA 01/2022 - 02/2009
9	RamucirumabIBA 10/2021 - 08/2014
9	CrizotinibIBA 01/2018 - 05/2012
8	B7-H1 AntigenIBA 01/2022 - 04/2016
8	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 09/2010
7	NivolumabIBA 01/2024 - 01/2018
7	atezolizumabIBA 01/2022 - 04/2016
7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 04/2005
6	amivantamab-vmjwIBA 11/2023 - 10/2021
6	selpercatinibIBA 11/2023 - 01/2020
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2015
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2019 - 10/2005
5	Alanine Transaminase (SGPT)IBA 01/2023 - 04/2016
5	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 11/2003
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 04/2005
4	LigandsIBA 04/2024 - 04/2015
4	avelumabIBA 09/2023 - 01/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2018
4	IpilimumabIBA 01/2022 - 11/2019
4	Circulating Tumor DNAIBA 01/2022 - 01/2017
4	ParaffinIBA 01/2020 - 05/2005
4	Thymidylate SynthaseIBA 01/2019 - 09/2010
4	Ifosfamide FDA LinkGeneric 01/2018 - 10/2003
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2017 - 08/2002
3	Cell-Free Nucleic AcidsIBA 02/2024 - 11/2015
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2020
3	ceritinibIBA 01/2023 - 01/2017
3	vandetanib (ZD6474)IBA 05/2020 - 04/2012
3	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2016

Therapy/Procedure

114	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
112	Therapeutics 02/2024 - 11/2003
28	Chemoradiotherapy 02/2024 - 10/2003
23	Radiotherapy 11/2023 - 01/2002
11	Immunotherapy 02/2024 - 12/2007
10	Combination Drug Therapy (Combination Chemotherapy) 02/2023 - 08/2002
9	Neoadjuvant Therapy 11/2020 - 09/2006
7	Aftercare (After-Treatment) 12/2020 - 10/2006
6	Precision Medicine 01/2023 - 05/2011
6	Salvage Therapy 02/2012 - 01/2007
5	Adjuvant Chemotherapy 01/2018 - 10/2003
3	Induction Chemotherapy 01/2021 - 07/2013